Page 4 - Augmedix Notes News Today

Perkins Capital Management Inc. increased its stake in shares of Augmedix, Inc. (OTCMKTS:AUGX – Get Rating) by 276.0% during the 4th quarter, Holdings Channel.com reports. The fund owned 1,680,428 shares of the company’s stock after purchasing an additional 1,233,528 shares during the quarter. Augmedix comprises about 2.8% of Perkins Capital Management Inc.’s portfolio, making the […]

Benchmark reiterated their buy rating on shares of Augmedix (OTCMKTS:AUGX – Get Rating) in a research note published on Friday, Benzinga reports. Benchmark currently has a $5.00 price objective on the stock. AUGX has been the topic of several other reports. Maxim Group boosted their price target on shares of Augmedix from $4.00 to $5.00 […]

Operator: Greetings, welcome to Augmedix Incorporated 2022 Fourth Quarter Earnings Conference Call. At this time, all participants will be in listen-only mode.

SPAR Group (NASDAQ:SGRP – Get Rating) and Augmedix (OTCMKTS:AUGX – Get Rating) are both small-cap business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, risk, valuation, earnings, profitability and institutional ownership. Profitability This table compares SPAR Group and Augmedix’s net […]

Augmedix (OTCMKTS:AUGX – Get Rating) is one of 228 public companies in the “Business services, not elsewhere classified” industry, but how does it weigh in compared to its competitors? We will compare Augmedix to similar companies based on the strength of its valuation, risk, analyst recommendations, profitability, dividends, earnings and institutional ownership. Earnings & Valuation […]

Augmedix (OTCMKTS:AUGX – Get Rating) and Grab (NASDAQ:GRAB – Get Rating) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk. Insider & Institutional Ownership 59.0% of Augmedix shares are owned by institutional […]

Augmedix (OTCMKTS: AUGX) has recently received a number of price target changes and ratings updates: 5/31/2022 – Augmedix was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Augmedix Inc. is a provider of remote medical documentation and live clinical support. Augmedix Inc. is based in […]

Augmedix (OTCMKTS:AUGX – Get Rating) is one of 227 publicly-traded companies in the “Business services, not elsewhere classified” industry, but how does it compare to its peers? We will compare Augmedix to similar businesses based on the strength of its valuation, analyst recommendations, risk, dividends, earnings, profitability and institutional ownership. Insider and Institutional Ownership 59.0% […]

Augmedix (OTCMKTS:AUGX – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Monday, Zacks.com reports. The firm currently has a $2.25 price target on the stock. Zacks Investment Research‘s target price points to a potential upside of 6.64% from the […]

Augmedix (OTCMKTS:AUGX – Get Rating) is one of 226 publicly-traded companies in the “Business services, not elsewhere classified” industry, but how does it compare to its peers? We will compare Augmedix to similar businesses based on the strength of its dividends, earnings, profitability, valuation, institutional ownership, analyst recommendations and risk. Institutional and Insider Ownership 59.0% […]